We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Lazard
LAZ
$4.43B
| $1.22M | ﹤0.01% |
23,700
-2,300
| -9% | -$123K |
|
877
SiTime
SITM
$20.7B
| $1.22M | ﹤0.01% |
5,684
-300
| -5% | -$61.1K |
|
878
Prestige Consumer Healthcare
PBH
$2.43B
| $1.22M | ﹤0.01% |
15,581
+1,100
| +8% | +$85.4K |
|
879
Ryder
R
$10.1B
| $1.21M | ﹤0.01% |
7,726
+100
| +1% | +$15.6K |
|
880
SiriusXM
SIRI
$9.43B
| $1.21M | ﹤0.01% |
53,061
+3,608
| +7% | +$92K |
|
881
Advanced Energy
AEIS
$13.2B
| $1.21M | ﹤0.01% |
10,437
+1,100
| +12% | +$124K |
|
882
Tanger
SKT
$4.42B
| $1.21M | ﹤0.01% |
35,353
+3,600
| +11% | +$125K |
|
883
Organon & Co
OGN
$3.6B
| $1.2M | ﹤0.01% |
80,365
+12,115
| +18% | +$197K |
|
884
Silicon Laboratories
SLAB
$7.28B
| $1.2M | ﹤0.01% |
9,637
| – | – |
|
885
Cousins Properties
CUZ
$4.93B
| $1.2M | ﹤0.01% |
39,020
+2,400
| +7% | +$73.6K |
|
886
Galicia Financial Group
GGAL
$7.23B
| $1.19M | ﹤0.01% |
19,165
+5,000
| +35% | +$275K |
|
887
Upstart Holdings
UPST
$3.01B
| $1.19M | ﹤0.01% |
19,400
+4,500
| +30% | +$281K |
|
888
Dycom Industries
DY
$12.3B
| $1.19M | ﹤0.01% |
6,851
| – | – |
|
889
Brunswick
BC
$5.29B
| $1.19M | ﹤0.01% |
18,400
-123,500
| -87% | -$9.68M |
|
890
CareTrust REIT
CTRE
$9.18B
| $1.19M | ﹤0.01% |
43,846
| – | – |
|
891
Apple Hospitality REIT
APLE
$3.75B
| $1.19M | ﹤0.01% |
77,218
-7,200
| -9% | -$112K |
|
892
Herc Holdings
HRI
$5.64B
| $1.19M | ﹤0.01% |
6,258
+400
| +7% | +$80.7K |
|
893
Celsius Holdings
CELH
$7.28B
| $1.18M | ﹤0.01% |
44,900
+9,700
| +28% | +$288K |
|
894
RadNet
RDNT
$6.08B
| $1.18M | ﹤0.01% |
16,900
+1,800
| +12% | +$133K |
|
895
SL Green Realty
SLG
$4.08B
| $1.18M | ﹤0.01% |
17,365
+1,900
| +12% | +$141K |
|
896
Moelis & Co
MC
$5.21B
| $1.18M | ﹤0.01% |
15,951
+4,200
| +36% | +$304K |
|
897
Academy Sports + Outdoors
ASO
$3.03B
| $1.17M | ﹤0.01% |
20,400
-1,800
| -8% | -$94.9K |
|
898
Commercial Metals
CMC
$7.98B
| $1.17M | ﹤0.01% |
23,600
-4,600
| -16% | -$259K |
|
899
Silgan Holdings
SLGN
$4.46B
| $1.17M | ﹤0.01% |
22,488
-4,800
| -18% | -$256K |
|
900
Dentsply Sirona
XRAY
$2.31B
| $1.17M | ﹤0.01% |
61,700
-6,400
| -9% | -$135K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.